Table 5.
Patients’ self-reported behaviors regarding unsupervised doses.
| N | Patients without additional unsupervised doses during the pandemic n (%) |
Patients with additional unsupervised doses during the pandemic n (%) |
χ2 | p value | |
|---|---|---|---|---|---|
| Able to take unsupervised doses as prescribed | 268 | 75 (70%) | 80 (50%) | 10.97 | <.001 |
| Lost or misplaced unsupervised doses | 269 | 16 (15%) | 38 (24%) | 3.11 | .08 |
| Unsupervised doses were stolen | 268 | 14 (13%) | 30 (19%) | 1.57 | .21 |
| Requested early refills | 269 | 26 (24%) | 50 (31%) | 1.55 | .21 |
| Shared unsupervised doses with others | 268 | 18 (17%) | 104 (65%) | 59.16 | < .001 |
| Traded unsupervised doses for food or other goods | 268 | 11 (10%) | 41 (26%) | 9.48 | .002 |
| Experienced opioid overdose(s) with or without emergency department visit | 268 | 14 (13%) | 25 (16%) | 0.37 | .54 |
| Visited the emergency department because of substance use | 268 | 10 (9%) | 15 (9%) | 0.00 | .98 |
| Admitted to hospital because of substance use | 265 | 7 (7%) | 19 (12%) | 2.05 | .15 |
Note: Analyses included patients who reported having at least one unsupervised dose during the pandemic. Analyses excluded patients prescribed depot buprenorphine, but included patients who reported being prescribed multiple forms of OAT. Patients were categorized as having additional unsupervised doses during the pandemic if they answered “yes” to a question asking about having additional unsupervised doses during the pandemic compared to prior to the pandemic. Percentages reflect the proportion of patients within each group (i.e., those with or without additional unsupervised doses) who acknowledged that the events listed in the table occurred.